While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

A number of Donald Trump supporters and vaccine skeptics have criticized the president after he talked up multibillion-dollar artificial intelligence infrastructure project, which, it was ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

Everest Medicines has established a fully integrated and clinically validated mRNA platform, encompassing antigen design, mRNA sequence optimization ... From a capital markets perspective, Everest ...

HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA ...

AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and development, today announced a ...